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Abstract
Background: Antinuclear antibodies are useful diagnostic tools in several autoimmune diseases.
However, the routine detection of nuclear envelope autoantibodies using immunofluorescence (IF)
is not always easy to perform in patients' sera because of the presence of autoantibodies to other
nuclear and cytoplasmic components which could mask the characteristic rim-like pattern of
nuclear envelope autoantibodies. This is particularly common in sera from patients with primary
biliary cirrhosis (PBC), which generaly have high titres of anti-mitochondrial antibodies. Therefore,
we have assayed a number of commercial slides and alternative fixation conditions to optimize the
detection of anti-nuclear envelope antibodies (ANEA) in PBC sera.
Methods: We have explored the presence of ANEA in 33 sera from patients with established PBC
using three different Hep2 commercial slides and home-made slides with HeLa and Hep2 cells fixed
with methanol, ethanol, 1% or 4% formaldehyde.
Results: We observed that the IF pattern was related to the cell type used (Hep2 or HeLa), the
manufacturer and the cell fixation scheme. When both cell lines were fixed with 1% formaldehyde,
the intensity of the cytoplasmic staining was considerably decreased regardless to the serum
sample, whereas the prevalence of cytoplasmic autoantibodies was significantly lowered, as
compared to any of the Hep2 commercial slide and fixation used. In addition, the prevalence of
ANEA was importantly increased in formaldehyde-fixed cells.
Conclusion: Immunofluorescence using appropriately fixed cells represent an easy, no time-
consuming and low cost technique for the routine screening of sera for ANEA. Detection of ANEA
is shown to be more efficient using formaldehyde-fixed cells instead of commercially available Hep2
cells.
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Background
Circulating antinuclear antibodies (ANA) is a diverse
group of autoantibodies found in patients with systemic
or organ specific autoimmune diseases and a variety of
infections, but also in asymptomatic normal individuals,
although in low titres. ANA screening helps establishing
diagnosis in patients with clinical features suggestive of an
autoimmune or connective tissue disorders, while exclud-
ing (at least partially) the possibility of an autoimmune
disorder in patients with few or uncertain clinical find-
ings. In addition, they assist in monitoring disease pro-
gression and activity. Nuclear envelope is a complex
structure consisting of outer and inner nuclear mem-
branes, nuclear pore complexes (NPC) and the nuclear
lamina [1]. Autoantibodies against nuclear envelope pro-
teins exhibit a characteristic rim-like/peripheral pattern in
IF. In a number of diseases, such as chronic fatigue syn-
drome, primary biliary cirrhosis and lupus or lupus-like
syndrome the detection of anti-nuclear envelope antibod-
ies may give an additional diagnostic clue [2-5]. In
chronic fatigue syndrome, [6] appr. 52% of patients
develop autoantibodies to components of the nuclear
envelope, mainly nuclear lamins. In systemic lupus ery-
thematosus [5] a strong association of autoantibodies to
human nuclear lamin B1 with lupus anticoagulant anti-
bodies (LAC) has been reported and suggested that the
presence of LAC without anti-lamin B1 may define a sub-
set of SLE patients at greater risk for thrombosis.
In PBC, a chronic destructive cholangitis, although ninety
percent of patients show circulating antimitochondrial
antibodies (AMA) [7], the presence of ANA is highly spe-
cific [8] and can be used as a "positive tool" in the diagno-
sis of AMA-negative PBC cases [9]. Indeed, 64% of sera
from PBC patients were found positive for ANA [10]. Sev-
eral proteins have been recognized as ANA targets in PBC,
such as Sp100 [11] and promyelocytic leukemia proteins
[12], the latter generating a multiple nuclear dot pattern in
IF. Antibodies against proteins of the nuclear pore com-
plex, such as gp210 and p62, have been reported [13,14],
being associated with the activity and severity of the dis-
ease [3]. In addition, it was recently suggested that anti-
p62 antibodies may be related to the progressive or
advanced state of PBC [4]. In rare cases (1–2%) antibodies
against lamin B receptor, an integral protein of the inner
nuclear membrane may be found [8]. Using standard IF
methods, the prevalence of ANEA in PBC, differs consid-
erably amidst references, varying between 29% and 58%
[4,13,15,16]. This discrepancy may be due to the use of
different commercially available slides, or to the simulta-
neous presence of other autoantibodies in patient's sera,
directed against different nucleoplasmic or cytoplasmic
antigens, possibly masking perinuclear staining.
In the present work we propose an alternative protocol,
using formaldehyde-fixed HeLa or Hep2 cells, to improve
recognition of nuclear envelope proteins by circulating
autoantibodies. The specificity of autoantibodies against
nuclear envelope antigens was also confirmed by immu-
noblotting using purified HeLa nuclei and nuclear enve-
lopes. Finally, the IF analysis of 33 sera from patients with
established PBC, using formaldehyde-fixed cells and three
commercially available slides showed that ANEA are more




Frozen (-80°C) serum samples from thirty three patients
(twenty nine women) with PBC were used. Median age at
the time of venesection was 60 years (ranging from 32 to
75 years). All patients had histologically proven PBC, 16
were at stage I-II, 6 at stage III and 11 at stage IV. Patients
were followed at the Department of Gastoenterology,
University Hospital of Heraklion, Greece, were on ursode-
oxycholic acid (15 mg/kg) sinse diagnosis, no one had
ever been on steroids or other immunomodulatory treat-
ment and no one had undergone liver transplantation.
Oral informed concent from all patients participating in
this study was taken, to use their blood samples for
research purposes. Ethical approval was issued by the Sci-
entific and Ethics Committee of the University Hospital of
Heraklion.
Cell lines and culture
Hep2 cells (ECACC 86030501) were found to have a
HeLa profile by DNA fingerprinting and therefore recently
re-designated as "HeLa derivative" cells. Hep2 (larynx and
cervical carcinoma) cells were obtained from the Euro-
pean Collection of Cell Cultures (ECACC, Salisbury, Wilt-
shire) and cervical carcinoma HeLa cells (CCL-2), from
the American Type Tissue Culture Collection (Manassas,
VA). Both cell lines were maintained at 37°C, in a humid-
ified atmosphere containing 5% CO2 and cultured in Dul-
becco's MEM or EMEM for HeLa and Hep2, respectively
(Biochrom, Berlin, Germany), supplemented with 10%
heat-inactivated fetal bovine serum, penicillin and strep-
tomycin.
Indirect immunofluorescence microscopy
Indirect immunofluorescence was performed as described
previously [17]. Briefly, Hep2 and HeLa cells grown on
coverslips were washed with PBS, fixed in 4% or 1% for-
maldehyde for 5 minutes at room temperature or in cold
(-20°C) methanol or ethanol for 5 minutes and permea-
bilized with Triton X-100. Fixed cells were incubated in
blocking buffer (phosphate buffered saline, pH 7.4, 0.5%
Triton X-100 and 1% fish skin gelatin) and then with sera
at a dilution of 1/80 in blocking buffer for 1 hour. TheBMC Immunology 2006, 7:20 http://www.biomedcentral.com/1471-2172/7/20
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specimens were stained with fluorescein conjugated anti-
human IgG, diluted and ready for use (Inova Diagnostics,
San Diego, CA). The same sera (dilution 1/80) were exam-
ined for the presence of ANA using fixed Hep2 cells from
3 different suppliers: Inova Diagnostics (San Diego, CA),
Zeus Scientific Inc. (Raritan, NJ) and bmd (Marne La Val-
lée, France). In all cases, detection was made by a supplied
FITC-coupled anti-human Ig antibody. In all cases, we
have followed the protocols suggested by the manufac-
turer. Fluorescence was routinely assayed in a Leica SP
confocal microscope and a standard fluorescence micro-
scope, with comparable results.
Isolation of cell nuclei and nuclear envelopes
To isolate nuclei and nuclear envelopes, HeLa cells were
detached from the culture dishes, centrifuged at 300 g and
washed three times with phosphate buffered saline pH
7.4, containing 1 mM PMSF. The pellet was resuspended
in an equal volume of ice-cold buffer H (10 mM Hepes-
KOH pH 7.4, 2 mM MgCl2, 0.1 mM EGTA, 1 mM DTT, 1
mM PMSF and 2 µg/ml each of leupeptin, pepstatin and
aprotinin) and Dounce-homogenized under careful phase
monitoring. The homogenate was centrifuged at 1200 g
for 10 minutes, yielding a pellet (nuclei) and a superna-
tant (cytoplasmic fraction). The nuclear fraction was
washed in buffer H, containing 150 mM NaCl and was
stored at -80°C until use.
Nuclear envelopes were prepared as described previously
[18]. Briefly, nuclei were solubilised in 20 mM Tris buffer
pH 8.5, containing 0.1 mM MgCl2, 0.5 mM PMSF, 1 mM
DTT, 10% sucrose and incubated with 2 mg/ml DNAse I
at room temperature for 15 minutes. DNAse digestion was
repeated in Tris buffer pH 7.5. The insoluble material rep-
resenting nuclear envelopes was separated by centrifuga-
tion and solubilised sequentially in high salt (2 M KCl)
buffer, secondly in 40 mM Tris-HCl pH 8.0, 0.1 mM
EGTA, 2 mM MgCl2, 1 mM DTT, 1 mM PMSF and finally
in ice-cold distilled H2O, in order to extract most of the
peripheraly attached material.
Immunoblotting
Thirty µg of HeLa nuclei or nuclear envelopes were elec-
trophoresed on a 12.5% SDS polyacrylamide gel and
transfered on nitrocellulose membrane. Immobilized
autoantigens were subjected to a denaturation/renatura-
tion process, in order to obtain correctly folded
autoepitopes and therefore optimize autoantibody reac-
tivity. Briefly, nitrocellulose membranes were first incu-
bated for 5 minutes in 50 mM Tris-HCl pH 8.0,
containing 20% propanol-2 and washed 3 times with
H20. Thereafter, proteins were initially denatured by incu-
bating membrane in 7 M Guanidine-HCl, 50 mM Tris-
HCl pH 8.0, 2 mM EDTA pH 8.0, 5 mM DTT and then
renatured in washing buffer (20 mM Tris-HCl pH 7.4, 155
mM NaCl, 0.1% Tween) for 10 minutes. Free sites on the
membrane were blocked in 20 mM Tris-HCl pH 7.4, 155
mM NaCl, 0.1% Tween, 1% fish skin gelatin overnight at
4°C. Membranes were incubated with sera at 1/300 dilu-
tion in blocking buffer for 1 hour at room temperature
and washed 3 times with the same buffer. Autoantibodies
were recognized using anti-human secondary antibodies
conjugated with HRP at a dilution of 1/10.000 in blocking
buffer and detected using the ECL system (Amersham-
Pharmacia, Buckinghamshire, UK).
Statistical analysis
Comparison of two values was made by calculating the z-
value and reporting to the normal distribution tables.
Comparison of percentages (probabilities) was made by
the calculation of χ2 score.
Results
Anti-nuclear envelope antibodies are specifically detected 
using formaldehyde-fixed HeLa cells
PBC is among autoimmune diseases in which ANEA are
usually detected. In the present study, we tested sera from
patients with diagnosed PBC; representative cytoplasmic
and nuclear envelope IF patterns are depicted in Figure 1.
HeLa cells cultured on coverslips and fixed either with 4%
or 1% formaldehyde were used. When cells were fixed
with 4% FA a peripheral nuclear pattern indicative of
nuclear envelope staining was observed, with the excep-
tion of sera 30 and 161, which presented an intense cyto-
plasmic staining and a non-conclusive nuclear envelope
pattern. However, fixation with 1% FA allowed the detec-
tion of nuclear envelope autoantibodies in serum 161
(Figure 1A).
In order to confirm the results obtained with IF (Figure
1A), we assayed detection of autoantigens by immunob-
lotting using purified nuclei and nuclear envelopes from
HeLa cells. Depending on their molecular weight, nuclear
envelope autoantigens recognized by autoantibodies
present in the sera examined could be grouped in two cat-
egories (Figure 1B): The first comprises autoantigens of
high molecular mass, recognized by sera 176 and 184,
while the second contains a protein of approximately 50
kDa recognized by all sera (27, 159, 161). Two additional
proteins with a molecular mass of ~90 kDa and 40 kDa
were recognized by serum 159, while serum 161 recog-
nized only the former. No signal was detected upon blot-
ting of the afore-mentioned nuclear extracts with a serum
containing anti-mitochondrial antibodies but not ANEA
as verified by IF (Figure 1, s30). Therefore, we concluded
that HeLa cells, appropriately fixed with FA, are suitable
substrates for the specific detection of ANEA in patients'
sera.BMC Immunology 2006, 7:20 http://www.biomedcentral.com/1471-2172/7/20
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(A) Immunostaining of HeLa cells fixed with 1% or 4% formaldehyde with PBC sera diluted 1/80, Bar = 20 µm Figure 1
(A) Immunostaining of HeLa cells fixed with 1% or 4% formaldehyde with PBC sera diluted 1/80, Bar = 20 µm. (B) Immunoblot-
ing depicting electrophoretically fractionated nuclei and nuclear envelopes (NEs) from HeLa cells that have been probed with 
serum 27 (s27), serum 159 (s159), serum 161 (s161), serum 184 (s184), serum 176 (s176) or serum 30 (s30) at a dilution 1/
300. At the left molecular mass markers at 125, 103, 49, 33, 23 and 18 kDa are indicated.BMC Immunology 2006, 7:20 http://www.biomedcentral.com/1471-2172/7/20
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Differential detection of anti-nuclear envelope antibodies 
by formaldehyde-fixed cells and commercially available 
Hep2 slides
Three different commercial slides/kits of Hep2 cells and
home-made slides of Hep2 and HeLa cells were used for
the detection of autoantibodies in patients' sera. The
rationale behind the use of these two cell types is that they
are both epithelial in origin (larynx and cervical carci-
noma for Hep2 and cervical carcinoma for HeLa), and
express the same genotype and a similar phenotype.
Characteristic immunofluorescence profiles of three com-
mercially available Hep2 slides and home-made slides of
Hep2 cells fixed with 1% or 4% formaldehyde, methanol
or ethanol are shown in Figure 2. In Figure 2A, typical
staining of sera using commercially available Hep2 slides,
is depicted. Although all sera exhibited a cytoplasmic
staining, its intensity varied depending on the substrate
used. In general, weaker cytoplasmic staining was
observed when slides from Zeus company were used. In
Hep2 slides from Inova, with the exception of serum 27,
no conclusive staining of the nuclear envelope was found:
the perinuclear pattern obtained with sera 152 and 161
was discontinuous in some cells (asterisks), indicating a
rather cytoplasmic staining, while sera 28 and 159 did not
show an accentuation of the peripheral staining, suggest-
ing failure of nuclear envelope antigen recognition. A dis-
continuous perinuclear staining was observed using slides
from bmd, whereas nuclear envelope pattern was revealed
in 3 sera (27, 152 and 159) on Zeus slides.
Analysis of the same sera using home-made slides of Hep2
cells resulted in different IF patterns depending on the fix-
ation conditions. Hep2 cells fixed with methanol or etha-
nol and to a lesser extent with 4% formaldehyde showed
an IF profile very similar to those obtained with commer-
cially available slides (compare Figure 2A and 2B). The IF
pattern was quite different when sera were tested on Hep2
Immunostaining of Hep2 cells with PBC sera Figure 2
Immunostaining of Hep2 cells with PBC sera. Commercially available slides with Hep2 cells (A) and normally growing Hep2 
cells (B) fixed with methanol, ethanol, 1% or 4% formaldehyde were stained with sera (s) 27, 28, 152, 159 and 161 diluted 1/80, 
Bar = 20 µm.BMC Immunology 2006, 7:20 http://www.biomedcentral.com/1471-2172/7/20
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cells fixed with 1% formaldehyde. As a rule, cytoplasmic
staining was considerably lowered or eliminated thus
revealing a nuclear envelope pattern (Figure 2).
We have further assayed the same sera using HeLa cells, a
cell line widely used in experimental studies (Figure 3). As
shown for Hep2 cells, when HeLa cells were fixed with 1%
formaldehyde, cytoplasmic staining was considerably
reduced and nuclear envelope was revealed as the pre-
dominant stained compartment (compare Figure 2B and
Figure 3).
Extending our analysis in all 33 sera samples from
patients with PBC, usually enriched in anti-mitochondrial
antibodies, we showed that the detection of different
groups of autoantibodies with IF varied considerably,
depending on the provider, the fixation conditions and
the cell type (Hep2, HeLa) used (Table 1). Moreover,
many of the examined sera presented both cytoplasmic
nuclear and/or nuclear envelope staining, while, a signifi-
cant number of sera recognised solely nucleoplasmic or
nuclear envelope antigens, depending on the substrate
used. Concerning the detection of cytoplasmic autoanti-
bodies, the three commercial tests and home-made slides
with cells fixed with 4%FA revealed a number of positive
cases, ranging from 51.5% to 75.7 %. In contrast, when
Hep2 or HeLa cells fixed with 1%FA were used, a signifi-
cantly lower number of positive cases, 30.3% and 27.2%,
respectively were detected (p < 0.05 at least by χ2 analysis,
as compared to the mean of the other tests). Although
nucleoplasmic staining seemed favoured in Zeus test
(positiveness was 54.5%) as compared to other substrates,
(ranging from 30.3% to 45.4%) no statistically significant
difference was found. Finally, HeLa and Hep2 cells, fixed
with either 1% or 4% FA were more efficient in the detec-
tion of ANEA, as compared to Inova and bmd kits, while
Zeus kit showed an equally higher number of ANEA pos-
itive cases (21.1%).
Discussion
The detection of ANA by IF is routinely used for the diag-
nosis of autoimmune diseases. In spite of a relative facil-
ity, parameters such as the IF substrates (tissue or cell
lines), the fixation conditions, the absence of a common
standard and the diagnostic ability of the examiner,
hinder the comparison of results performed in different
laboratories. In addition, the presence of a variety of
autoantibodies, directed against diverse cytoplasmic or
nuclear antigens may obscur the detection of a specific
class of autoantibodies with potential diagnostic rele-
vance in a given disease. Such cases are difficult to resolve
and a number of alternative methods are subsequently
applied, in order to identify the target of circulating
autoantibodies.
Usually, the detection of ANEA is based on the character-
istic perinuclear rim-like fluorescence. Nevertheless, as
shown in Figures 2 and 3, in some cases, this pattern may
be masked by the presence of autoantibodies directed
against other cytoplasmic or nucleoplasmic elements. In
the present study, we report that formaldehyde-fixed cells
are more adequate to reveal the presence of ANEA, com-
pared to commercially available Hep2 cell substrates
(Table 1). It is known that antibody reactivity could be
modulated by the type of fixation. Within this study, we
showed that both normal (4%) and mild (1%) formalde-
hyde fixation are essential to detect the totality of ANEA,
since specific autoantigens were recognized only under a
particular fixation condition. In most cases, mild fixation
of cells with 1% formaldehyde reduced their cytoplasmic
staining. It is likely that 1% FA may not adequately fix
mitochondrial antigens, thus unmasking nuclear enve-
lope structures stained by nuclear envelope autoantibod-
ies. In addition we showed that the NE pattern obtained
in 1% FA fixed cells is specific and irrelevant to autoanti-
gen mislocalisation. Indeed, immunoblot analysis of
nuclear and nuclear envelope fraction with sera, exhibit-
Table 1: Prevalence of cytoplasmic, nucleoplasmic and NE antibodies by immunofluorescence using various substrates and fixation 
schemes in 33 PBC patients' sera.
Cell type/fixation autoantigen localization
Cytoplasmic nucleoplasmic NE
No. % No. % No. %
HeLa/4%FA 19 57.5 10 30.3 11 33.3
HeLa/1%FA 9 27.2 12 36.4 13 39.4
Hep2/4%FA 25 75.7 13 39.4 11 33.3
Hep2/1%FA 10 30.3 15 45.4 15 45.4
Hep2 Inova 18 54.5 13 39.4 5 15.1
Hep2 bmd 19 57.5 12 36.4 4 12.1
Hep2 Zeus 17 51.5 18 54.5 7 21.2BMC Immunology 2006, 7:20 http://www.biomedcentral.com/1471-2172/7/20
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Immunostaining of HeLa cells with PBC sera Figure 3
Immunostaining of HeLa cells with PBC sera. Normally growing HeLa cells fixed with methanol, ethanol, 1% or 4% formalde-
hyde were stained with sera (s) 27, 28, 152, 159 and 161 diluted 1/80, Bar = 20 µm.BMC Immunology 2006, 7:20 http://www.biomedcentral.com/1471-2172/7/20
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ing perinuclear staining revealed the presence of specific
nuclear envelope autoantigens. The proteins of high
molecular mass recognized by autoantibodies of sera 176
and 184 correspond probably to gp210 antigen of the
NPC. The rest of autoantigens detected by immunoblot-
ing with an apparent molecular mass of 90 kDa, 50 kDa
and 40 kDa could be components of the NPC, not yet
characterized. Recently, anti-NPC antibodies against pro-
teins with similar molecular mass (86 kDa, 54 kDa and 39
kDa) were identified in PBC sera using the same method,
with frequencies of 29%, 30% and 18%, respectively [4].
Besides serum titration, IF guides further diagnostic proce-
dures, eg ELISA for specific autoantibodies or dot blot
assays, relying on the fluorescence pattern. However, in
sera with a mixture of autoantibodies, the pattern for
ANEA in IF is not always evident and easy to confirm,
especially when AMA are detected in a high titre. In fact,
results reported in various studies show an under- or an
over-estimation of ANEA [4,13,15,16]. The same is also
true for a number of other classes of autoantibodies.
Indeed, analysis of PBC sera has shown that IF is less sen-
sitive in detecting circulating autoantibodies than immu-
noblotting and enzymatic immunoassay [3,16]. More
than 70% of the patients with PBC, who were AMA-nega-
tive by IF, were found AMA-positive using recombinant
autoantigens in a newly developed ELISA [19]. In con-
trast, in another study, 21% of positive sera for ANEA by
IF did not react with nuclear envelope components using
immunoblotting [20]. Generally, immunoblotting analy-
sis showed that antibodies against proteins of the nuclear
pore complex are associated with a more active and severe
liver disease in PBC [3] or with an advanced state of PBC
[4].
Conclusion
Results of the present study indicate that efficient detec-
tion of ANEA may be obtained by indirect IF analysis of
patients' sera using cells appropriately fixed with formal-
dehyde. In particular, mild fixation reduces considerably
the staining of cytoplasmic or nucleoplasmic antigens in
Hep2 and HeLa cells and permits a better resolution of
nuclear membrane epitopes. In view of the potential diag-
nostic significance of ANEA in a number of rheumatic dis-
eases, as well as in PBC, we consider that this method
might be a valuable additional tool to the clinical labora-
tory practice.
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